What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
Why did a failed Novartis drug trial tank Amgen’s shares? And how is taxpayer money funding quantum-computing companies? Plus, will people pay $2,000 for a foldable iPhone? Host Imani Moise discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from WSJ Your Money Briefing
What’s News in Markets: Markets Digest Shocks, Tokenized Stocks, Buffett Steps Down
How Suze Orman Starts Her Week
What’s News in Markets: Bond Selloff, Big Nvidia Deals, Apple’s New CEO
What’s News in Markets: Nvidia’s Victory Lap, Callaway Lands in the Rough, Sneaker Slump
Get summaries like this every morning.
Free AI-powered recaps of WSJ Your Money Briefing and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.